NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
25 October 2024 - 12:00AM
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)
(“NeuroOne” or the “Company”), a medical technology company focused
on improving surgical care options and outcomes for patients
suffering from neurological disorders, today announced that it will
be participating in The ThinkEquity Conference on October 30, 2024,
at the Mandarin Oriental Hotel in New York. The ThinkEquity
Conference gathers institutional investors, corporate clients, and
other industry professionals to highlight groundbreaking
innovations and financial strategies.
Ron McClurg, CFO, will be presenting at 9:00 am ET on October
30th. The Company will also hold one-on-one investor meetings
throughout the day. Interested investors can register to attend and
schedule on-on-one meetings here.
The presentation will also be live-streamed at the following
link: https://wsw.com/webcast/tep25/nmtc/1682208.
About ThinkEquityThinkEquity is a boutique
investment bank founded by professionals who have collaborated for
over a decade, collectively financing over $50 billion in public
and private capital raises, restructurings, and mergers and
acquisitions. Past ThinkEquity conferences have featured over 70
company presentations, 700+ attendees, and 500+ one-on-one
meetings, providing a valuable platform for companies and investors
to connect. To register to attend The ThinkEquity Conference,
please follow this link.
About NeuroOneNeuroOne Medical Technologies
Corporation is a developmental stage company committed to providing
minimally invasive and hi-definition solutions for EEG recording,
brain stimulation and ablation solutions for patients suffering
from epilepsy, Parkinson's disease, dystonia, essential tremors,
chronic pain due to failed back surgeries and other related
neurological disorders that may improve patient outcomes and reduce
procedural costs. The Company may also pursue applications for
other areas such as depression, mood disorders, pain, incontinence,
high blood pressure, and artificial intelligence. For more
information, visit www.nmtc1.com.
IR ContactQuinn Callanan, CFA or Brian
Prenoveau, CFAMZ Group – MZ North AmericaNMTC@mzgroup.us (949)
694-9594
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From Nov 2024 to Dec 2024
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From Dec 2023 to Dec 2024